Overview


According to FutureWise analysis the market for Epilepsy Treatment Devices in 2023 is US$ 0.52 billion, and is expected to reach US$ 0.76 billion by 2031 at a CAGR of 4.82%.

Epilepsy refers to a group of non-communicable neurological conditions that is characterized by recurrent seizures. These episodes can cause injuries such as broken bones, or even accidents. Epilepsy is characterized by seizures that recur, even if there is no immediate cause. Epilepsy is not defined as isolated seizures that are caused by a specific cause, such as poisoning. Because of the alarming nature of their symptoms, epilepsy sufferers may experience different treatments in different parts of the world. Epileptic seizures are caused by abnormal and excessive neuronal activity in the cortex of the brain. This can be seen in an individual's electroencephalogram (EEG). This is a common symptom of epilepsy. Some cases can be attributed to brain injury, stroke, brain tumors, or infections, while others are the result of epileptogenesis. A small number of cases are linked directly to known genetic mutations. A diagnosis includes excluding other conditions, such as fainting, and determining whether there is another cause, such as alcohol withdrawal, or electrolyte problems. An EEG can confirm epilepsy, but it is not possible to rule out normal tests.

There are many factors that can cause epilepsy, including genetic and acquired causes. In some cases, these factors may interact. Brain trauma, stroke, tumors, and brain problems that result from a previous infection are all known and established causes. About 60% of cases are undiagnosed. The incidence of epilepsies due to congenital, genetic, or developmental conditions is higher in younger people than it is for older people. Brain tumors and strokes, however, are more common in older people. Seizures can also be a result of other health issues. If they happen around a specific cause such as a stroke or head injury, toxic intake, or metabolic problem, or metabolic problem they are called acute symptoms seizures. They are part of the seizure-related disorders broader classification than epilepsy. Although the exact mechanism of epilepsy remains a mystery, we do know a lot about its network and cellular mechanisms. It is not known under what circumstances the brain switches to the activity of a seizure due to its excessive synchronization. The role of microRNA (miRNA), levels, seems to be the most important. MicroRNAs (miRNAs), a small family of non-coding RNAs, control multiple proteins' expression levels by decreasing mRNA stability. They could also be therapeutic targets for epilepsy. This decreases the ability of excitatory neurons during epilepsy to fire during this time. This could be due to malfunctioning inhibitory neurons or changes in Ion Channel. The "seizure focal" is a location where seizures can develop. An additional mechanism that may cause epilepsy is the up-regulation or down-regulation of inhibitory circuits after injury to the brain. These secondary epilepsies are caused by epileptogenesis. The failure of the blood barrier could also be a cause, as it would allow substances to enter the brain.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Epilepsy Treatment Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Epilepsy Treatment Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Cerbomed GmbH.
  • ElectroCore Inc
  • Cyberonics Inc
  • NeuroPace Inc
  • Boston Scientific
  • Medtronic
  • Medpage Ltd
  • Cadwell industries
  • General Electric
  • Philips N.V.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product Type

  • Wearable devices
  • Coventional Devices
  • Implantable Devices

By Technology

  • Vagus Nerve Stimulator
  • Respnsive Neurostimulation
  • Deep Brain Stimulation
  • Accelerometry

By End User

  • Hospitals
  • Ambulatory Surgical Cenetrs
  • Neurology Centers
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Epilepsy Treatment Devices Market By Product Type, By Technology, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Epilepsy Treatment Devices Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Epilepsy Treatment Devices Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Epilepsy Treatment Devices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Epilepsy Treatment Devices Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Wearable devices
        2. Coventional Devices
        3. Implantable Devices

  • 8.   Epilepsy Treatment Devices Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Vagus Nerve Stimulator
        2. Respnsive Neurostimulation
        3. Deep Brain Stimulation
        4. Accelerometry

  • 9.   Epilepsy Treatment Devices Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Ambulatory Surgical Cenetrs
        3. Neurology Centers
        4. Others

  • 10.   North America Epilepsy Treatment Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Epilepsy Treatment Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Epilepsy Treatment Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Epilepsy Treatment Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Epilepsy Treatment Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Cerbomed GmbH.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. ElectroCore Inc
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Cyberonics Inc
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. NeuroPace Inc
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Boston Scientific
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Medtronic
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Medpage Ltd
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Cadwell industries
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. General Electric
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Philips N.V.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients